PGA vs PDO Sutures: Complete Clinical Comparison Guide [2026]

What Are PGA Sutures?

PGA (Polyglycolic Acid) sutures are synthetic absorbable sutures manufactured from poly(glycolic acid), a homopolymer of glycolic acid. PGA was the first entirely synthetic absorbable suture material, introduced in the early 1970s, and remains the most widely used absorbable suture in general surgery worldwide. The polymer is produced by the ring-opening polymerization of glycolide, yielding a highly crystalline (45-55% crystallinity) material with predictable degradation properties.

PGA sutures degrade by hydrolysis — water molecules cleave the ester bonds in the polymer backbone, breaking the polymer into glycolic acid fragments that are metabolized and excreted. The high crystallinity of PGA produces a fast, predictable degradation rate: PGA sutures retain approximately 75% of original tensile strength at 2 weeks and provide complete mass absorption within 60-90 days. This strength retention profile aligns with the healing timeline of most soft tissues, which regain mechanical integrity within 3-6 weeks.

Structurally, PGA sutures are braided from multiple fine filaments and coated with a lubricating agent — typically a copolymer of glycolide and lactide, or caprolactone-based compounds — to improve tissue passage and handling. The braided structure gives PGA sutures excellent knot security and smooth, predictable handling. However, the interstices of the braided structure can harbor bacteria, making PGA less suitable for heavily contaminated wounds than monofilament alternatives.

Desmo Care PGA Suture Products

Desmo Care manufactures three PGA suture products covering the full range of clinical applications:

• DesmoNex — Standard PGA suture with 28-35 day tissue support and 60-90 day absorption. Available in USP sizes 8/0 through 2 for general and soft tissue surgery.
• DesmoNex Rapid — Fast-absorbing PGA formulation providing 7-10 day tissue support and complete absorption in approximately 42 days. Designed for superficial closure, episiotomy repair, and pediatric skin closure where early suture dissolution is preferred.
• Absorbex — High-strength PGA suture coated with Glycomer 370 for enhanced lubrication and smooth passage. Provides up to 30 days of tissue support with the same 60-90 day absorption profile, used in demanding applications such as fascial closure and abdominal wall repair.

All Desmo Care PGA sutures are sterilized by Ethylene Oxide, available in a full range of needle configurations, and CE marked under EU MDR 2017/745.

What Are PDO Sutures?

PDO (Polydioxanone) sutures are synthetic absorbable monofilament sutures manufactured from poly-p-dioxanone, a polyester polymer containing an ether linkage in the repeating unit. This ether linkage reduces the crystallinity of the material (approximately 55% for PDO vs. 45-55% for PGA) and — crucially — slows the rate of hydrolytic degradation relative to pure polyesters like PGA. The result is a substantially longer strength retention profile and absorption timeline.

PDO sutures were introduced in the 1980s to fill the clinical gap between medium-term absorbable sutures (PGA) and permanent non-absorbable sutures (polypropylene). They are produced as monofilament — a single continuous fiber — giving them different handling characteristics from braided PGA. PDO sutures retain approximately 70% of original tensile strength at 2 weeks, and approximately 50% at 6 weeks, making them uniquely suited to procedures where tissue healing takes longer than 4-6 weeks.

The monofilament structure of PDO confers an important clinical advantage: resistance to bacterial wicking. Unlike braided sutures, monofilament PDO does not harbor bacteria in interstices, reducing the risk of suture-line infection in high-risk patients. PDO's smooth surface also produces minimal tissue drag, allowing delicate tissue passage with reduced trauma.

The metabolic end product of PDO hydrolysis is primarily hydroxyethyl glycolate and small amounts of ethylene glycol, both of which are cleared by normal metabolic pathways. Tissue reactivity to PDO is very minimal, with a lower inflammatory response compared to braided PGA sutures.

Desmo Care PDO Suture Product

Desmo Care manufactures DesmoPol, a monofilament PDO suture providing up to 180 days of tissue support and complete absorption in 180-210 days. DesmoPol is available in USP sizes 7/0 through 2, with a full range of needle options for cardiovascular, orthopedic, obstetric, pediatric, and general surgery applications.

PGA vs PDO: Side-by-Side Comparison

The table below compares PGA (as represented by DesmoNex and Absorbex) and PDO (as represented by DesmoPol) across all clinically relevant parameters. This comparison applies to standard-grade products; fast-absorbing PGA variants (DesmoNex Rapid) have different profiles.

Tensile Strength Retention Over Time: PGA vs PDO

The strength retention profile is the most critical variable in suture selection for absorbable materials. The following data compares in vivo tensile strength retention at measured intervals for PGA (DesmoNex/Absorbex) and PDO (DesmoPol). All values represent approximate percentage of original implanted tensile strength.

Data derived from manufacturer specifications and published suture biomechanics literature. In vivo values may vary based on tissue type, patient health, and wound conditions.

When to Choose PGA Over PDO

PGA sutures are the appropriate choice in the majority of general soft tissue surgery cases. Their 28-35 day tissue support window matches the healing timeline of most internal soft tissues — bowel anastomoses, fascial layers, subcutaneous tissue, and mucosal closures typically attain sufficient intrinsic strength within 3-4 weeks.

Clinical Scenarios Favoring PGA

• General abdominal and gastrointestinal surgery: Fascial closure, peritoneal closure, bowel anastomosis, and organ repairs where healing occurs within 3-5 weeks.
• Gynecological and obstetric procedures: Episiotomy repair, uterine closure following cesarean section, and vaginal vault closure. DesmoNex Rapid is the standard for perineal closure.
• Oral and maxillofacial surgery: Mucosal closure where tissue heals rapidly (10-14 days) and faster suture absorption is preferred.
• Ophthalmic surgery: Fine-gauge PGA (8/0) for conjunctival and scleral closure provides adequate short-term strength with predictable absorption.
• High-volume general procedures: Cost considerations may favor PGA where PDO's extended strength retention is not clinically necessary.

Handling Advantages of PGA

The braided structure of PGA sutures gives them handling characteristics that many surgeons prefer, particularly those trained on braided absorbable sutures. Key handling properties include:

• Knot security: Braided sutures have higher knot security than monofilaments — fewer throws required to achieve a secure knot, reducing knot volume in tissue.
• Pliability: Braided PGA is more pliable and less prone to the memory effect that causes monofilament PDO to spring back toward its coiled shape.
• Consistent pull-through: The coating on DesmoNex and Absorbex provides smooth, consistent tissue passage with minimal sawing or drag.

These properties make PGA particularly favored in laparoscopic procedures, where suture handling is more challenging, and in situations where rapid, reliable knot tying is important. PGA sutures account for approximately 40-50% of all absorbable suture usage globally, reflecting their versatility and cost-effectiveness.

When to Choose PDO Over PGA

PDO sutures are indicated when tissue healing is expected to take longer than 4-6 weeks, or when the consequences of premature suture failure are severe. With 50% tensile strength retained at 6 weeks (versus minimal for PGA), DesmoPol provides meaningful mechanical support through the remodeling phase of wound healing, not just the initial repair phase.

Clinical Scenarios Requiring Extended Support

• Cardiovascular and thoracic surgery: Pediatric cardiac repairs benefit from absorbable sutures that persist long enough to support healing across the cardiac cycle, while eventually absorbing to allow tissue growth. PDO's 180-day support window is well-matched to pediatric cardiac healing timelines.
• Orthopedic soft tissue repair: Periosteal closure, joint capsule repair, and ligament augmentation require suture strength beyond 4-6 weeks as these tissues heal slowly. DesmoPol provides support through the collagen maturation phase.
• Fascial closure in malnourished or immunocompromised patients: Healing may be delayed in patients with diabetes, malnutrition, steroid therapy, or immune compromise. PDO's extended strength retention provides a margin of safety when healing is unpredictable.
• Abdominal closure in high-risk patients: For patients at elevated risk of wound dehiscence (obesity, chronic cough, elevated intra-abdominal pressure), PDO provides a 50% strength advantage over PGA at 6 weeks — the critical window for fascial dehiscence.
• Obstetric cerclage: Cervical cerclage procedures require suture retention for weeks to months; PDO's extended profile is appropriate.

Infection Resistance: The Monofilament Advantage

One of the most clinically significant differences between PGA and PDO is the suture's susceptibility to bacterial colonization. Braided PGA sutures can harbor bacteria in the spaces between individual filaments, creating a protected environment that resists host immune defenses and antibiotic penetration — a phenomenon known as bacterial wicking.

Monofilament PDO (DesmoPol) has no interstices, eliminating this pathway. In contaminated surgical fields or patients at elevated infection risk, PDO is the safer absorbable suture choice. Studies indicate that monofilament sutures are associated with lower rates of suture-line infection in contaminated wounds compared to equivalent braided sutures. For clean-contaminated or contaminated procedures requiring an absorbable suture, PDO should be strongly considered over PGA.

PGA vs PDO by Surgical Specialty

The following table provides specialty-level guidance on PGA vs PDO selection. Both materials may be used across multiple specialties; the table highlights the typical primary choice and rationale for each clinical setting.

Desmo Care PGA and PDO Products

Desmo Care manufactures a complete portfolio of PGA and PDO sutures, all CE marked under EU MDR 2017/745 and produced in an ISO 13485:2016 certified facility. The following products cover the clinical range from fast-absorbing general closure to extended-support cardiovascular and orthopedic applications.

Frequently Asked Questions: PGA vs PDO Sutures